Molecular and Functional Differences Induced in Thrombospondin-1 by the Single Nucleotide Polymorphism Associated with the Risk of Premature, Familial Myocardial Infarction

A serine (Ser-700) amino acid rather than an asparagine (Asn-700) at residue 700 of thrombospondin-1 has been linked to an increased risk for development of premature, familial heart attacks. We now have identified both functional and structural differences between the Ser-700 and Asn-700 thrombospo...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 279; no. 20; pp. 21651 - 21657
Main Authors Narizhneva, Natalya V, Byers-Ward, Vicky J, Quinn, Martin J, Zidar, Frank J, Plow, Edward F, Topol, Eric J, Byzova, Tatiana V
Format Journal Article
LanguageEnglish
Published United States American Society for Biochemistry and Molecular Biology 14.05.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A serine (Ser-700) amino acid rather than an asparagine (Asn-700) at residue 700 of thrombospondin-1 has been linked to an increased risk for development of premature, familial heart attacks. We now have identified both functional and structural differences between the Ser-700 and Asn-700 thrombospondin-1 variants. The Ser-700 variant increased the rate and extent of platelet aggregation and showed increased surface expression on platelets compared with the Asn-700 variant. These differences could be ascribed to an enhanced interaction of the Ser-700 variant with fibrinogen on the platelet surface and are consistent with a prothrombotic phenotype in Ser-700 individuals. The Ser-700 variant thrombospondin-1 was conformationally more labile than the Asn-700 variant as demonstrated by increased susceptibility to proteolytic digestion and enhanced susceptibility to unfolding by denaturants. These data suggest a potential molecular and cellular basis for a genetic risk factor associated with early onset myocardial infarction.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Recipient of an American Heart Association Fellowship (0325229B).
To whom correspondence may be addressed: Dept. of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-445-9490; Fax: 216-445-9595; E-mail: topole@ccf.org.
To whom correspondence may be addressed: Joseph J. Jacobs Ctr. for Thrombosis and Vascular Biology, Dept. of Molecular Cardiology, Cardiology and Taussig Cancer Ctr., Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-445-9490; Fax: 216-445-9595.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M311090200